Complications of pneumothorax in computed tomography-guided transthoracic needle biopsy and prognostic factors: study on patients with tumor-like lung lesions.

IF 2.1 3区 医学 Q3 RESPIRATORY SYSTEM
Journal of thoracic disease Pub Date : 2024-11-30 Epub Date: 2024-11-29 DOI:10.21037/jtd-24-955
Thanh Nguyen Ai Tran, Tung Ba Nguyen, Vu Hoang Anh Nguyen, Thanh Vu-Tri
{"title":"Complications of pneumothorax in computed tomography-guided transthoracic needle biopsy and prognostic factors: study on patients with tumor-like lung lesions.","authors":"Thanh Nguyen Ai Tran, Tung Ba Nguyen, Vu Hoang Anh Nguyen, Thanh Vu-Tri","doi":"10.21037/jtd-24-955","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Transthoracic biopsy has proven to be an effective procedure, especially for peripheral lung lesions, in obtaining samples that can definitively diagnose the underlying pathology. Despite its effectiveness, studies have demonstrated that it is associated with complications such as pneumothorax and hemoptysis. This study aims to evaluate the incidence of these complications and identify prognostic factors in patients who underwent a transthoracic biopsy.</p><p><strong>Methods: </strong>This retrospective cohort analysis included adults from Thu Duc City Hospital, a sub-urban hospital who underwent transthoracic biopsy from 2017 to 2022. Complications that were evaluated included pneumothorax and hemoptysis. Separate logistic regression models estimated the association of pneumothorax or hemoptysis and selected baseline patient demographic and clinical characteristics.</p><p><strong>Results: </strong>Among 221 patients who underwent transthoracic biopsy, 27.6% experienced pneumothorax complications, 19.9% had hemoptysis, and 5.4% had both. No air embolism was recorded. Most of the complications were mild and limited with medical management. Among patients who experienced pneumothorax, 6.6% (4/61) required chest tube drainage. Biopsy in tumors with a distance from chest wall to tumor edge of more than 20 mm and skin to tumor edge of more than 40 mm was associated with a higher risk of pneumothorax complication. Using the area under the receiver operating characteristic (AUROC) curve, a threshold of 23 mm for chest wall to tumor edge and 39.4 mm for skin to tumor edge could help predict pneumothorax with significant sensitivities and specificities.</p><p><strong>Conclusions: </strong>This retrospective study demonstrated that approximately half of patients undergoing thoracic biopsy experienced complications. It was suggested that pneumothorax could be predicted by measuring the distance from the tumor edge to the chest wall and the skin to have better preoperation preparation and potentially mitigate the issue.</p>","PeriodicalId":17542,"journal":{"name":"Journal of thoracic disease","volume":"16 11","pages":"7499-7510"},"PeriodicalIF":2.1000,"publicationDate":"2024-11-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11635216/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of thoracic disease","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.21037/jtd-24-955","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/11/29 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Transthoracic biopsy has proven to be an effective procedure, especially for peripheral lung lesions, in obtaining samples that can definitively diagnose the underlying pathology. Despite its effectiveness, studies have demonstrated that it is associated with complications such as pneumothorax and hemoptysis. This study aims to evaluate the incidence of these complications and identify prognostic factors in patients who underwent a transthoracic biopsy.

Methods: This retrospective cohort analysis included adults from Thu Duc City Hospital, a sub-urban hospital who underwent transthoracic biopsy from 2017 to 2022. Complications that were evaluated included pneumothorax and hemoptysis. Separate logistic regression models estimated the association of pneumothorax or hemoptysis and selected baseline patient demographic and clinical characteristics.

Results: Among 221 patients who underwent transthoracic biopsy, 27.6% experienced pneumothorax complications, 19.9% had hemoptysis, and 5.4% had both. No air embolism was recorded. Most of the complications were mild and limited with medical management. Among patients who experienced pneumothorax, 6.6% (4/61) required chest tube drainage. Biopsy in tumors with a distance from chest wall to tumor edge of more than 20 mm and skin to tumor edge of more than 40 mm was associated with a higher risk of pneumothorax complication. Using the area under the receiver operating characteristic (AUROC) curve, a threshold of 23 mm for chest wall to tumor edge and 39.4 mm for skin to tumor edge could help predict pneumothorax with significant sensitivities and specificities.

Conclusions: This retrospective study demonstrated that approximately half of patients undergoing thoracic biopsy experienced complications. It was suggested that pneumothorax could be predicted by measuring the distance from the tumor edge to the chest wall and the skin to have better preoperation preparation and potentially mitigate the issue.

计算机断层扫描引导下经胸腔穿刺活检的气胸并发症及预后因素:对肺部肿瘤样病变患者的研究。
背景:经胸活检已被证明是一种有效的检查方法,尤其是对周围肺部病变而言,它可以获得样本,从而明确诊断潜在的病理变化。尽管效果显著,但研究表明它与气胸和咯血等并发症有关。本研究旨在评估这些并发症的发生率,并确定接受经胸活检患者的预后因素:这项回顾性队列分析纳入了2017年至2022年期间接受经胸活检的城郊医院--顺德市医院的成人患者。评估的并发症包括气胸和咯血。单独的逻辑回归模型估算了气胸或咯血与选定的患者人口统计学和临床特征基线的相关性:结果:在221名接受经胸活检的患者中,27.6%出现气胸并发症,19.9%出现咯血,5.4%同时出现气胸和咯血。没有空气栓塞的记录。大多数并发症都很轻微,通过药物治疗也能控制。在出现气胸的患者中,6.6%(4/61)需要进行胸管引流。在胸壁到肿瘤边缘距离超过 20 毫米、皮肤到肿瘤边缘距离超过 40 毫米的肿瘤中进行活检,发生气胸并发症的风险较高。根据接收者操作特征曲线下面积(AUROC),胸壁到肿瘤边缘的阈值为23毫米,皮肤到肿瘤边缘的阈值为39.4毫米,这有助于预测气胸,且具有显著的敏感性和特异性:这项回顾性研究表明,约有一半接受胸部活检的患者出现了并发症。建议通过测量肿瘤边缘到胸壁和皮肤的距离来预测气胸的发生,从而做好术前准备,减少并发症的发生。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of thoracic disease
Journal of thoracic disease RESPIRATORY SYSTEM-
CiteScore
4.60
自引率
4.00%
发文量
254
期刊介绍: The Journal of Thoracic Disease (JTD, J Thorac Dis, pISSN: 2072-1439; eISSN: 2077-6624) was founded in Dec 2009, and indexed in PubMed in Dec 2011 and Science Citation Index SCI in Feb 2013. It is published quarterly (Dec 2009- Dec 2011), bimonthly (Jan 2012 - Dec 2013), monthly (Jan. 2014-) and openly distributed worldwide. JTD received its impact factor of 2.365 for the year 2016. JTD publishes manuscripts that describe new findings and provide current, practical information on the diagnosis and treatment of conditions related to thoracic disease. All the submission and reviewing are conducted electronically so that rapid review is assured.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信